Appili Therapeutics Inc. APLI.TO
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -103.98% | -59.95% | 25.91% | 30.26% | 40.93% |
| Total Depreciation and Amortization | -56.12% | -39.18% | -28.00% | 5.21% | -2.97% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -56.43% | -78.25% | -55.41% | -7.67% | 50.85% |
| Change in Net Operating Assets | 186.28% | 1,159.86% | 262.54% | -76.34% | -52.68% |
| Cash from Operations | -241.65% | -259.42% | 92.02% | -397.83% | 264.33% |
| Capital Expenditure | -- | -- | 100.00% | 58.33% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 100.00% | 28.57% | -440.00% |
| Total Debt Issued | -- | -- | -100.00% | -100.00% | -100.00% |
| Total Debt Repaid | 74.61% | 59.55% | 14.23% | -7.41% | -10.69% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 302.90% | -6.82% | -40.30% | -13.54% | 27.71% |
| Cash from Financing | 296.48% | -24.48% | -114.93% | -210.00% | -151.66% |
| Foreign Exchange rate Adjustments | 11.97% | -102.14% | 1,769.23% | 7,087.50% | 5,950.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -224.25% | -207.47% | 96.78% | -231.75% | 445.18% |